Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether pentoxifylline associated to pentavalent
antimony has a higher cure rate than pentavalent antimony alone in the treatment of cutaneous
leishmaniasis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Paulo Roberto Lima Machado
Collaborators:
Conselho Nacional de Desenvolvimento Científico e Tecnológico Federal University of Bahia Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais (INCT-DT)